Yasir B. Al-Wakeel
2017
In 2017, Yasir B. Al-Wakeel earned a total compensation of $301.9K as Former Chief Financial Officer and Head of Corporate Development at Merrimack Pharmaceuticals, a 64% decrease compared to previous year.
Compensation breakdown
| Bonus | $116,667 |
|---|---|
| Salary | $179,308 |
| Other | $5,891 |
| Total | $301,866 |
Al-Wakeel received $179.3K in salary, accounting for 59% of the total pay in 2017.
Al-Wakeel also received $116.7K in bonus and $5.9K in other compensation.
Rankings
In 2017, Yasir B. Al-Wakeel's compensation ranked 13,330th out of 14,666 executives tracked by ExecPay. In other words, Al-Wakeel earned more than 9.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,330 out of 14,666 | 9th |
Division Manufacturing | 5,243 out of 5,772 | 9th |
Major group Chemicals And Allied Products | 1,896 out of 2,075 | 9th |
Industry group Drugs | 1,581 out of 1,731 | 9th |
Industry Pharmaceutical Preparations | 1,219 out of 1,333 | 9th |
Source: SEC filing on April 27, 2018.
Al-Wakeel's colleagues
We found six more compensation records of executives who worked with Yasir B. Al-Wakeel at Merrimack Pharmaceuticals in 2017.
2017
Richard Peters
Merrimack Pharmaceuticals
Chief Executive Officer
2017
Jeffrey Munsie
Merrimack Pharmaceuticals
General Counsel
2017
Daryl Drummond
Merrimack Pharmaceuticals
Head of Research
2017
Sergio Santillana
Merrimack Pharmaceuticals
Chief Medical Officer
2017
Jean Franchi
Merrimack Pharmaceuticals
Chief Financial Officer
2017
Gary Crocker
Merrimack Pharmaceuticals